These compounds may interact with:
Cholesteryl ester transfer protein
Potentially involved in: age related macular degeneration; atherosclerosis; acquired metabolic disease; cardiovascular system disease; metabolic syndrome x; carcinoma; lipid metabolism disorder; macular degeneration; type 2 diabetes mellitus; coronary artery disease; diabetes mellitus; obesity; basilar artery insufficiency; cerebrovascular disease; cardiovascular diseases; hypercholesterolemia; hypercholesterolemia, familial; hyperlipidemia; hyperlipoproteinemias; hypertensive disease
Disease data sourced from Pharos.